Free Trial

Lipocine (LPCN) SEC Filings & 10K Form

Lipocine logo
$3.62 -0.02 (-0.55%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$3.69 +0.07 (+1.96%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Lipocine SEC Filings

DateFilerForm TypeView
05/14/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
4:31 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
8:30 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
8:30 AM
Lipocine (Filer)
Form DEF 14A
04/10/2025
3:05 PM
Lipocine (Filer)
Form PRE 14A
04/03/2025
3:31 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
8:45 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
8:30 AM
Lipocine (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2025
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:00 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
5:04 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:46 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
6:47 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4/A
12/30/2024
7:03 PM
Fogarty Krista (Reporting)
Lipocine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
7:04 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
5:06 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
8:45 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
5:09 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
3:37 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:05 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
5:04 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
8:39 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
10:23 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
5:19 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
5:20 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
7:15 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
7:15 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
8:00 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:39 PM
Fink Jeffrey Arvin (Reporting)
Lipocine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:41 PM
Higuchi John W. (Reporting)
Lipocine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Washington Is Broke—and Eyeing Your Savings Next (Ad)

Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.

Get your free guide now by clicking here >>
06/07/2024
4:43 PM
Jene Jill M. (Reporting)
Lipocine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:45 PM
Lipocine (Issuer)
Ono Richard Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:48 PM
Lipocine (Issuer)
Papapetropoulos Spyros (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:32 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
4:15 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LPCN) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners